Compare Duolingo Inc (DUOL) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Tenet Healthcare Corporation — how do they compare? Duolingo Inc trades at $151.49 (market cap $7.10B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 2.9× Duolingo Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 137 Days and Tenet Healthcare Corporation for 15 Days on average.
| DUOL | THC | |
|---|---|---|
Market Cap | $7.10B | $20.92B |
Volume | 922,471 | 455,764 |
Sector | Technology | Health |
52-Week High | $341.08 | $280.77 |
52-Week Low | $90.03 | $161.37 |
Typical Hold Time | 137 Days | 15 Days |
Enterprise Value | $5.87B | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DUOL trades at $151.72, up 2.42% today, with a bullish technical outlook and strong support near $149. The company reported robust fundamentals, with Q2 2026 EPS beating expectations at $0.66 versus $0.604, and revenue growth accelerating to $1.04 billion in 2025. Operating cash flow surged to $387.82 million, reflecting strong operational efficiency.
The stock presents a compelling growth story with high net margins of 35.87% and consistent earnings beats, though valuation multiples like EV/EBITDA of 33.96 suggest premium pricing. Key risks include insider selling and competitive pressures in edtech. Analyst consensus is mixed with a $140.63 price target, indicating cautious optimism amid near-term volatility.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
